Hill Dickinson has advised MedPal AI Plc (AIM:MPAL), a digital health platform, on its admission to AIM and a £2 million fundraising by way of an institutional placing and a retail offer through the Winterflood Retail Access Platform (WRAP).
MedPal is a UK-based digital health and artificial intelligence (AI) company focused on wellness management. The Company’s core product is a non-clinical, digital health app that aggregates and monitors users’ health metrics and provides wellness guidance. The MedPal app can connect to over 100 fitness apps and wearables on Apple iOS and Google Android operating systems, aggregating an individual’s health data into one unified profile. Medpal uses AI to provide wellbeing monitoring, lifestyle advice and bio-hacks based on real-time data.
MedPal listed on 26 August with a market capitalisation of approximately £16.5 million.
The Hill Dickinson team was led by Corporate partner Jaspal Sekhon, with assistance from Natalia Fryda (senior associate), Amelia Chung (associate), Ellie Hicken (trainee solicitor) and Rianne Byott (solicitor apprentice) in the Corporate team. Jamie Foster (partner), Ambika Pugalia (associate), Michael Ambrose-Howard (associate) and Sophie Vella (associate) delivered expert advice from the Commercial Health team, alongside Laura Marginson (senior associate) in the Employment Team.
We are delighted to have supported MedPal on its successful IPO. The transaction showcases our combined capital markets and commercial health expertise to support innovative businesses – such as MedPal – in the digital health sector. We wish MedPal every success as a listed company.Jaspal Sekhon
Corporate Partner
Commenting on the deal, Jaspal Sekhon said: “We are delighted to have supported MedPal on its successful IPO. The transaction showcases our combined capital markets and commercial health expertise to support innovative businesses – such as MedPal – in the digital health sector. We wish MedPal every success as a listed company. The listing continues the trend of improved market conditions for the UK capital markets after several challenging years (MedPal is the 14th IPO on AIM so far in 2025, exceeding the total of 11 AIM IPOs in 2024). The capital markets team at Hill Dickinson continues to see an uptick in new listings and in particular secondary fundraises.”